查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1824285

2025年全球增生性瘢痕和瘢痕疙瘩治疗市场报告

Hypertrophic And Keloid Scar Treatment Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年，增生性瘢痕和瘢痕疙瘩治疗市场将快速成长，到2029年将达到124.6亿美元，年复合成长率（CAGR）为10.1%。预测期内的成长归因于微创干预措施的兴起、疤痕修復技术的进步、人们对联合治疗日益增长的兴趣、认知度的提高和早期疗育，以及全球美学趋势。预测期内的主要趋势包括新型注射疗法、协同联合治疗、以患者为中心的方法、疤痕评估技术以及用于后续观察和咨询的远端医疗。

未来五年10.1%的成长预测比我们先前的预测略有下降，下降了0.1%。这一下降主要源自于美国与其他国家之间关税的影响。贸易摩擦可能导致从德国和台湾进口的硅胶片和冷冻治疗设备价格上涨，从而扰乱美国的疤痕管理，导致术后恢復时间延长，重组手术的后续费用增加。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，贸易摩擦的影响可能会更加广泛。

由于交通事故和烧烫伤病例的增加，增生性瘢痕和瘢痕疙瘩治疗市场预计将持续成长。至少涉及一辆车和一人身的交通事故需要关注并进行有效治疗，以消除由此造成的疤痕。增生性瘢痕和瘢痕疙瘩的治疗在降低疤痕高度和硬度方面发挥重要作用，有助于市场扩张。例如，美国) 2022 年 8 月的统计数据显示，2022 年前三个月机动车事故死亡人数与 2021 年同期相比增加了近 7%，这凸显了此类情况下瘢痕治疗的必要性。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球增生性瘢痕和瘢痕疙瘩治疗：PESTEL分析（政治、社会、技术、环境、法律、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球肥厚性瘢痕和瘢痕疙瘩治疗市场：成长率分析
  • 全球增生性瘢痕和瘢痕疙瘩治疗市场表现：规模与成长，2019-2024
  • 全球增生性瘢痕与瘢痕疙瘩治疗市场预测：规模与成长，2024-2029年，2034年
  • 全球增生性瘢痕和瘢痕疙瘩治疗：总目标市场（TAM）

第六章 市场细分

  • 全球增生性瘢痕和瘢痕疙瘩治疗市场（按治疗类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 冷冻疗法
  • 手术切除
  • 压缩绷带
  • 病灶内注射5-Fluorouracil
  • 表面X射线
  • 病灶内注射皮质类固醇
  • 其他治疗方法
  • 全球增生性瘢痕和瘢痕疙瘩治疗市场：按产品、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 外用产品
  • 雷射产品
  • 注射
  • 其他产品
  • 全球增生性瘢痕和瘢痕疙瘩治疗市场表现及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 增生性瘢痕
  • 瘢痕疙瘩
  • 全球增生性瘢痕和瘢痕疙瘩治疗市场：按最终用途、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊所
  • 其他最终用户
  • 全球肥厚性瘢痕和瘢痕疙瘩治疗市场：冷冻疗法细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 液态液态氮冷冻疗法
  • 病灶内冷冻疗法
  • 全球增生性瘢痕和瘢痕疙瘩治疗市场：依手术切除类型细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 单纯切除术
  • 切除并植皮
  • 全球肥厚性瘢痕和瘢痕疙瘩治疗市场：按压缩绷带细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 弹性绷带加压绷带
  • 硅胶加压绷带
  • 全球增生性瘢痕和瘢痕疙瘩治疗市场：按病灶内註射 5-Fluorouracil（按类型）细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 单独5-FU治疗
  • 与皮质类固醇一起使用
  • 全球增生性瘢痕和瘢痕疙瘩治疗市场：按表面X射线细分、类型、性能和预测，2019-2024年、2024-2029年、2034年
  • 低剂量X射线治疗
  • X射线与其他治疗方法相结合
  • 全球增生性疤痕及瘢痕疙瘩治疗市场：依病灶内皮质类固醇注射细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 曲安奈德注射液
  • 与5-Fluorouracil合併使用
  • 全球肥厚性瘢痕和瘢痕疙瘩治疗市场：依其他治疗方法细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 雷射治疗
  • 放射线治疗
  • 干扰素治疗

第七章 区域和国家分析

  • 全球增生性瘢痕和瘢痕疙瘩治疗市场：按地区、结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球增生性瘢痕和瘢痕疙瘩治疗市场：按国家/地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 增生性瘢痕和瘢痕疙瘩治疗市场：竞争格局
  • 肥厚性瘢痕和瘢痕疙瘩治疗市场：公司简介
    • Smith & Nephew plc Overview, Products and Services, Strategy and Financial Analysis
    • Merz Pharmaceutical LLC Overview, Products and Services, Strategy and Financial Analysis
    • Lumenis Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Enaltus LLC Overview, Products and Services, Strategy and Financial Analysis
    • Sonoma Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Molnlycke Health Care AB
  • Suneva Medical Inc.
  • Pacific World Corporation
  • Perrigo Company plc
  • Cynosure Inc.
  • Alliance Pharma plc
  • Newmedical Technology Inc.
  • HRA Pharma
  • Scar Heal Inc.
  • McKesson Medical Surgical Inc.
  • Johnson & Johnson Private Limited
  • Medtronic plc
  • 3M Company
  • Sinclair Pharma plc
  • Avita Medical

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年增生性瘢痕疙瘩治疗市场：哪些国家将提供新机会
  • 2029年增生性瘢痕和瘢痕疙瘩治疗市场：细分领域带来新机会
  • 2029年增生性瘢痕疙瘩治疗市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24216u

Hypertrophic and keloid scar treatment involves addressing scars that either remain within the boundaries of the original wound (hypertrophic) or extend beyond those boundaries and do not regress (keloids). Hypertrophic scars are contained within the area of the initial injury, while keloids spread outside the boundaries of the initial damage.

The main treatments for hypertrophic and keloid scars include cryotherapy, surgical excision, pressure dressings, intralesional 5-fluorouracil, superficial X-ray, intralesional corticosteroid injection, and others. Cryotherapy is a medical procedure that uses extremely cold liquid or a cryoprobe to freeze and destroy abnormal tissue. It is employed to destroy the core of keloid scars while preserving surface-level cells and tissues. Various products, including topical products, laser products, injectables, and others, are used during treatment. The end-users of hypertrophic and keloid scar treatment include hospitals, clinics, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The hypertrophic and keloid scar treatment market research report is one of a series of new reports from The Business Research Company that provides hypertrophic and keloid scar treatment market statistics, including hypertrophic and keloid scar treatment industry global market size, regional shares, competitors with a hypertrophic and keloid scar treatment market share, detailed hypertrophic and keloid scar treatment market segments, market trends and opportunities, and any further data you may need to thrive in the hypertrophic and keloid scar treatment industry. This hypertrophic and keloid scar treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hypertrophic and keloid scar treatment market size has grown strongly in recent years. It will grow from $7.72 billion in 2024 to $8.49 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to the rising incidence of hypertrophic and keloid scars, advancements in scar assessment, widespread adoption of topical treatments, surgical and invasive procedures, and patient demand for scar improvement.

The hypertrophic and keloid scar treatment market size is expected to see rapid growth in the next few years. It will grow to $12.46 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to emerging minimally invasive interventions, advancements in scar revision techniques, growing interest in combination therapies, increasing awareness and early intervention, and global aesthetic trends. Major trends in the forecast period include emerging injectable therapies, combination therapies for synergistic effects, patient-centric approaches, scar assessment technologies, and telemedicine for follow-up and consultations.

The forecast of 10.1% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. scar management by inflating prices of silicone gel sheets and cryotherapy devices imported from Germany and Taiwan, resulting in delayed post-surgical recovery and higher reconstructive surgery follow-up costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The hypertrophic and keloid scar treatment market is anticipated to witness growth due to an increase in the number of road accidents and burn cases. Road accidents involving at least one vehicle and individuals necessitate attention and effective treatment to address resulting scars. Hypertrophic and keloid scar treatments play a crucial role in lowering the height and tightness of scars, contributing to the market's expansion. For instance, statistics from the National Highway Traffic Safety Administration in August 2022 revealed a nearly 7% increase in motor vehicle traffic accident fatalities during the first three months of 2022 compared to the same period in 2021, highlighting the need for scar treatments in such cases.

The increasing popularity of aesthetic procedures is anticipated to drive growth in the hypertrophic and keloid scar treatment market in the future. Aesthetic procedures refer to non-invasive or minimally invasive cosmetic treatments aimed at enhancing an individual's appearance and addressing various cosmetic concerns. Treatments for hypertrophic and keloid scars are integral to these procedures, as they help reduce and improve the appearance of raised scars, resulting in a smoother and more visually appealing outcome. For example, in June 2024, The International Society of Aesthetic Plastic Surgery (ISAPS), a US-based organization for plastic surgeons, reported that in 2023, liposuction remained the most common surgical procedure, with over 2.2 million procedures performed, sustaining its lead from 2022. Breast augmentation and eyelid surgery closely followed, both showing notable growth. Specifically, eyelid surgery saw a remarkable 24% increase, reaching more than 1.7 million procedures, while rhinoplasty rose by 21.6%, totaling 1.1 million procedures compared to the previous year. Thus, the rise in aesthetic procedures is propelling the hypertrophic and keloid scar treatment market.

Leading companies in the hypertrophic and keloid scar treatment market are strategically focusing on the development of clinically proven solutions, particularly those based on silicone, such as medical-grade silicone strips. These therapeutic products made from high-quality silicone are formulated to promote scar healing and reduction, offering an effective solution for various scar types. An example is Scar Erase, a UK-based company, which launched clinically tested silicone strips designed for scar healing and reduction, catering to hypertrophic, keloid, post-surgery, and stretch mark scars.

Major players in the market are also investing in advanced dermatological lines that leverage innovative technologies such as Microcyn technology. This technology accelerates wound healing, combats infections, and alleviates symptoms, providing clinically proven solutions. Sonoma Pharmaceuticals, a US-based pharmaceutical company, introduced a line of office dispensed products, including Regenacyn Plus, which is clinically proven to enhance the appearance of keloid and hypertrophic scars, offering relief from itch and pain while reducing infection risk.

In July 2022, Sinclair Pharma, a UK-based aesthetics company, completed the acquisition of Viora Ltd. The financial details of the acquisition remain undisclosed. This strategic move is expected to grant Sinclair access to Viora's portfolio of non-invasive and minimally invasive aesthetic devices. Additionally, the acquisition is anticipated to facilitate Sinclair's entry into the US market on a commercial scale. Viora Ltd., based in the US, specializes in providing medical aesthetic devices and solutions, including offerings related to scar and stretch mark revision, acne clearance, and various other aesthetic treatments.

Major companies operating in the hypertrophic and keloid scar treatment market include Smith & Nephew plc, Merz Pharmaceutical LLC, Lumenis Ltd., Enaltus LLC, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical Inc., Pacific World Corporation, Perrigo Company plc, Cynosure Inc., Alliance Pharma plc, Newmedical Technology Inc., HRA Pharma, Scar Heal Inc., McKesson Medical Surgical Inc., Johnson & Johnson Private Limited, Medtronic plc, 3M Company, Sinclair Pharma plc, Avita Medical, Stratpharma AG, Revitol Corporation Inc., Scarfade, Biodermis, Mederma, Silagen

North America was the largest region in the hypertrophic and keloid scar treatment market in 2024. Asia-pacific is expected to be the fastest-growing region in the global hypertrophic and keloid scar treatment market report during the forecast period. The regions covered in the hypertrophic and keloid scar treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hypertrophic and keloid scar treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hypertrophic and keloid scar treatment market consist of revenues earned by entities by providing occlusive dressings, compression therapy, intralesional corticosteroid injections, cryosurgery, excision, radiation therapy, laser therapy, interferon (IFN) therapy, doxorubicin, bleomycin, and verapamil. The market value includes the value of related goods sold by the service provider or included within the service offering. The hypertrophic and keloid scar treatment market also includes sales of skin camouflage, silicon gels, and skin needling. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hypertrophic And Keloid Scar Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hypertrophic and keloid scar treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hypertrophic and keloid scar treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hypertrophic and keloid scar treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Treatment: Cryotherapy; Surgical Excision; Pressure Dressings; Intralesional 5-Fluorouracil; Superficial X-Ray; Intralesional Corticosteroid Injection; Other Treatments
  • 2) By Products: Topical Products; Laser Products; Injectables; Other Products
  • 3) By Scar: Hypertrophic Scars; Keloid Scars
  • 4) By End-Use: Hospitals; Clinics; Other End-Users
  • Subsegments:
  • 1) By Cryotherapy: Liquid Nitrogen Cryotherapy; Intralesional Cryotherapy
  • 2) By Surgical Excision: Simple Excision; Excision With Skin Grafting
  • 3) By Pressure Dressings: Elastic Bandage Pressure Dressings; Silicone Gel Pressure Dressings
  • 4) By Intralesional 5-Fluorouracil: Standalone 5-FU Treatment; Combination With Corticosteroids
  • 5) By Superficial X-Ray: Low-Dose X-Ray Therapy; Combination X-Ray With Other Treatments
  • 6) By Intralesional Corticosteroid Injection: Triamcinolone Acetonide Injection; Combination With 5-Fluorouracil
  • 7) By Other Treatments: Laser Therapy; Radiotherapy; Interferon Therapy
  • Companies Mentioned: Smith & Nephew plc; Merz Pharmaceutical LLC; Lumenis Ltd.; Enaltus LLC; Sonoma Pharmaceuticals Inc.; Molnlycke Health Care AB; Suneva Medical Inc.; Pacific World Corporation; Perrigo Company plc; Cynosure Inc.; Alliance Pharma plc; Newmedical Technology Inc.; HRA Pharma; Scar Heal Inc.; McKesson Medical Surgical Inc.; Johnson & Johnson Private Limited; Medtronic plc; 3M Company; Sinclair Pharma plc; Avita Medical; Stratpharma AG; Revitol Corporation Inc.; Scarfade; Biodermis; Mederma; Silagen
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hypertrophic And Keloid Scar Treatment Market Characteristics

3. Hypertrophic And Keloid Scar Treatment Market Trends And Strategies

4. Hypertrophic And Keloid Scar Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hypertrophic And Keloid Scar Treatment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hypertrophic And Keloid Scar Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hypertrophic And Keloid Scar Treatment Market Growth Rate Analysis
  • 5.4. Global Hypertrophic And Keloid Scar Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hypertrophic And Keloid Scar Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hypertrophic And Keloid Scar Treatment Total Addressable Market (TAM)

6. Hypertrophic And Keloid Scar Treatment Market Segmentation

  • 6.1. Global Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cryotherapy
  • Surgical Excision
  • Pressure Dressings
  • Intralesional 5-Fluorouracil
  • Superficial X-Ray
  • Intralesional Corticosteroid Injection
  • Other Treatments
  • 6.2. Global Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Topical Products
  • Laser Products
  • Injectables
  • Other Products
  • 6.3. Global Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hypertrophic Scars
  • Keloid Scars
  • 6.4. Global Hypertrophic And Keloid Scar Treatment Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Other End-Users
  • 6.5. Global Hypertrophic And Keloid Scar Treatment Market, Sub-Segmentation Of Cryotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid Nitrogen Cryotherapy
  • Intralesional Cryotherapy
  • 6.6. Global Hypertrophic And Keloid Scar Treatment Market, Sub-Segmentation Of Surgical Excision, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Simple Excision
  • Excision With Skin Grafting
  • 6.7. Global Hypertrophic And Keloid Scar Treatment Market, Sub-Segmentation Of Pressure Dressings, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Elastic Bandage Pressure Dressings
  • Silicone Gel Pressure Dressings
  • 6.8. Global Hypertrophic And Keloid Scar Treatment Market, Sub-Segmentation Of Intralesional 5-Fluorouracil, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standalone 5-FU Treatment
  • Combination With Corticosteroids
  • 6.9. Global Hypertrophic And Keloid Scar Treatment Market, Sub-Segmentation Of Superficial X-Ray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Low-Dose X-Ray Therapy
  • Combination X-Ray With Other Treatments
  • 6.10. Global Hypertrophic And Keloid Scar Treatment Market, Sub-Segmentation Of Intralesional Corticosteroid Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Triamcinolone Acetonide Injection
  • Combination With 5-Fluorouracil
  • 6.11. Global Hypertrophic And Keloid Scar Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laser Therapy
  • Radiotherapy
  • Interferon Therapy

7. Hypertrophic And Keloid Scar Treatment Market Regional And Country Analysis

  • 7.1. Global Hypertrophic And Keloid Scar Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hypertrophic And Keloid Scar Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hypertrophic And Keloid Scar Treatment Market

  • 8.1. Asia-Pacific Hypertrophic And Keloid Scar Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hypertrophic And Keloid Scar Treatment Market

  • 9.1. China Hypertrophic And Keloid Scar Treatment Market Overview
  • 9.2. China Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hypertrophic And Keloid Scar Treatment Market

  • 10.1. India Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hypertrophic And Keloid Scar Treatment Market

  • 11.1. Japan Hypertrophic And Keloid Scar Treatment Market Overview
  • 11.2. Japan Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hypertrophic And Keloid Scar Treatment Market

  • 12.1. Australia Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hypertrophic And Keloid Scar Treatment Market

  • 13.1. Indonesia Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hypertrophic And Keloid Scar Treatment Market

  • 14.1. South Korea Hypertrophic And Keloid Scar Treatment Market Overview
  • 14.2. South Korea Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hypertrophic And Keloid Scar Treatment Market

  • 15.1. Western Europe Hypertrophic And Keloid Scar Treatment Market Overview
  • 15.2. Western Europe Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hypertrophic And Keloid Scar Treatment Market

  • 16.1. UK Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hypertrophic And Keloid Scar Treatment Market

  • 17.1. Germany Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hypertrophic And Keloid Scar Treatment Market

  • 18.1. France Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hypertrophic And Keloid Scar Treatment Market

  • 19.1. Italy Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hypertrophic And Keloid Scar Treatment Market

  • 20.1. Spain Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hypertrophic And Keloid Scar Treatment Market

  • 21.1. Eastern Europe Hypertrophic And Keloid Scar Treatment Market Overview
  • 21.2. Eastern Europe Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hypertrophic And Keloid Scar Treatment Market

  • 22.1. Russia Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hypertrophic And Keloid Scar Treatment Market

  • 23.1. North America Hypertrophic And Keloid Scar Treatment Market Overview
  • 23.2. North America Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hypertrophic And Keloid Scar Treatment Market

  • 24.1. USA Hypertrophic And Keloid Scar Treatment Market Overview
  • 24.2. USA Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hypertrophic And Keloid Scar Treatment Market

  • 25.1. Canada Hypertrophic And Keloid Scar Treatment Market Overview
  • 25.2. Canada Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hypertrophic And Keloid Scar Treatment Market

  • 26.1. South America Hypertrophic And Keloid Scar Treatment Market Overview
  • 26.2. South America Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hypertrophic And Keloid Scar Treatment Market

  • 27.1. Brazil Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hypertrophic And Keloid Scar Treatment Market

  • 28.1. Middle East Hypertrophic And Keloid Scar Treatment Market Overview
  • 28.2. Middle East Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hypertrophic And Keloid Scar Treatment Market

  • 29.1. Africa Hypertrophic And Keloid Scar Treatment Market Overview
  • 29.2. Africa Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hypertrophic And Keloid Scar Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Hypertrophic And Keloid Scar Treatment Market Competitive Landscape
  • 30.2. Hypertrophic And Keloid Scar Treatment Market Company Profiles
    • 30.2.1. Smith & Nephew plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merz Pharmaceutical LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Lumenis Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Enaltus LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Sonoma Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Hypertrophic And Keloid Scar Treatment Market Other Major And Innovative Companies

  • 31.1. Molnlycke Health Care AB
  • 31.2. Suneva Medical Inc.
  • 31.3. Pacific World Corporation
  • 31.4. Perrigo Company plc
  • 31.5. Cynosure Inc.
  • 31.6. Alliance Pharma plc
  • 31.7. Newmedical Technology Inc.
  • 31.8. HRA Pharma
  • 31.9. Scar Heal Inc.
  • 31.10. McKesson Medical Surgical Inc.
  • 31.11. Johnson & Johnson Private Limited
  • 31.12. Medtronic plc
  • 31.13. 3M Company
  • 31.14. Sinclair Pharma plc
  • 31.15. Avita Medical

32. Global Hypertrophic And Keloid Scar Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hypertrophic And Keloid Scar Treatment Market

34. Recent Developments In The Hypertrophic And Keloid Scar Treatment Market

35. Hypertrophic And Keloid Scar Treatment Market High Potential Countries, Segments and Strategies

  • 35.1 Hypertrophic And Keloid Scar Treatment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hypertrophic And Keloid Scar Treatment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hypertrophic And Keloid Scar Treatment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer